These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4772483)

  • 1. [Intravenous injection of kanamycin in tuberculosis].
    Kertselli IŭS
    Probl Tuberk; 1973; 51(2):78. PubMed ID: 4772483
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravenous injection of kanamycin in tuberculosis].
    Kertselli IuS
    Probl Tuberk; 1973; 51(2):79-80. PubMed ID: 4772484
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary clinical studies on the efficacy and tolerance of the antibiotic kanendomycin in the phthisiological field].
    Moreo GC; Mazza L
    G Ital Chemioter; 1976; 23(1):17-20. PubMed ID: 801000
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 8. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
    Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
    Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
    [No Abstract]   [Full Text] [Related]  

  • 10. [A comparison of the effects of the combined therapy with CPM+1321 TH+CS, KM+1321 TH+CS and KM+1314 TH+CS in the treatment of pulmonary tuberculosis].
    Iizuka Y; Iwasaki T; Fujioka K
    Kekkaku; 1969 Mar; 44(3):109-15. PubMed ID: 5783307
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hearing damages in prolonged kanamycin therapy].
    Rempt E
    Z Laryngol Rhinol Otol; 1970 Aug; 49(8):504-9. PubMed ID: 5314873
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of pulmonary tuberculosis by kanamycin].
    Gomi J
    Nihon Ishikai Zasshi; 1967 Dec; 58(12):1389-92. PubMed ID: 5628030
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of inoperable phthisics by transparietal intracavitary continuous drip administration of bacteriostatics].
    Favez G; Elias W
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1851-4. PubMed ID: 5704709
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of tuberculosis resistant to 1st line drugs with rifampycin and ethambutol, twice a week, with an initial supplement of kanamycin].
    Santiviago C; Estrada A; Zúñiga E; Sepúlveda R; Alvarez R; Gay O; Zimmermann I; Hiriart M; Orrego H; Farga V
    Rev Med Chil; 1971 Dec; 99(12):928-33. PubMed ID: 5157620
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-radiological considerations on the treatment of tuberculous caverns with bronchoinstillations of kanamycin-terramycin].
    De Rosa G; Gatti L; Vullo P
    Minerva Radiol; 1966; 11(7):381-96. PubMed ID: 5981944
    [No Abstract]   [Full Text] [Related]  

  • 20. [Disorders of auditory and vestibular function in patients with pulmonary tuberculosis after administration of antibiotics with ototoxic action].
    Golanov VS; Markovskiĭ SA; Kinal' PF
    Probl Tuberk; 1973; 51(12):30-2. PubMed ID: 4782099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.